Navigation Links
United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
Date:10/27/2011

ts.

(1) See definition of earnings before non-cash charges, a non-GAAP financial measure, and a reconciliation of net income to earnings before non-cash charges below. Expenses

The table below summarizes research and development expense by major project and non-project components (dollars in thousands):Three Months Ended September 30,20112010PercentageChangeProject and non-project component:Cardiopulmonary

$

74,125$

17,510323.3%Share-based compensation

(22,966)14,149(262.3) %Other

8,2748,678(4.7) %Total research and development expense

$

59,433$

40,33747.3%Cardiopulmonary. The increase in expenses related to our cardiopulmonary projects for the quarter ended September 30, 2011 was attributable largely to increases of $46.3 million in expenses incurred in connection with our July 2011 amended license agreement with Toray Industries, Inc. and $5.0 million incurred in connection with the closing of our license agreement with Pluristem Ltd.  

Share-based compensation. The decrease in share-based compensation for the quarter ended September 30, 2011, compared to the same quarter in 2010, corresponded to a reduction in share-based compensation recognized in connection with our share tracking awards plans as a result of the decline in our stock price.

The table below summarizes selling, general and administrative expense by major categories (dollars in thousands):Three Months EndedSeptember 30,20112010PercentageChangeCategory:General and administrative

$

24,972$

18,11837.8%Sales and marketing

15,82210,30453.6%Share-based compensation

(24,138)17,171(240.6) %Total selling, general and administrative expense

$

16,656$

45,593(63.5) %General and administrative. The increase in general and administrative expenses for the quarter ended September 30, 2011, compared to the same quarter in 2010, corresp
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
2. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
3. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
4. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
5. Full-day "United Nations" Online Investor Conference: October 6th at RetailInvestorConferences.com
6. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
7. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
8. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
9. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
10. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
11. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  Alere Inc. (NYSE: ... of its failure to timely file its Quarterly Report on ... (the "Form 10-Q"), it has received a notice from the ... not in compliance with the NYSE,s continued listing requirements under ... NYSE Listed Company Manual. The reason for ...
(Date:5/26/2015)... NJ (PRWEB) May 26, 2015 OHAUS ... balances and scales, is set to release a new ... of quality-driven laboratory instruments. For over a century, the ... in weighing technology throughout the world. Now in ... has gone Beyond Weighing to include water quality measurement. ...
(Date:5/26/2015)... 26, 2015 Pharmaco-Kinesis Corporation (PKC) announced today ... at Shutters on the Beach in Santa ... of the Company,s innovative Metronomic Biofeedback Pump (MBP), a ... chemotherapy over time to a target site of the ... biofeedback system in real-time.  ...
(Date:5/26/2015)... , May 26, 2015 Mr. Kevin Xu ... thanks President Barack Obama and President Bill ... time of loss of Dr. Rongxiang Xu , Kevin,s ... a leader ahead of his time, Dr. Xu,s commitment to ... leave a legacy that will not be forgotten. As a ...
Breaking Biology Technology:OHAUS Corporation to Release New Water Analysis Meters in 2015 2OHAUS Corporation to Release New Water Analysis Meters in 2015 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Dr. Rongxiang Xu, Beyond A Legend 2
... Guide New Service Offering, PHILADELPHIA, Feb. 7 ... Alzheimer,s risk assessment service,with the appointment of a medical ... leading laboratory testing companies in the world., "Our ... accurate,information about their genetic risk, help them understand and ...
... Calif., Feb. 7 Documents,detailing the California stem ... relations firm reveal an agency,leadership worried about the ... secret by channeling it through an outside law ... said today., The stem cell institute, a ...
... In a speech to be delivered Tuesday,February 12th, ... Conference,at the New York Grand Hyatt Hotel, U.S. ... Thompson, will propose that,prevention is the solution for ... together experts from throughout the health care industry,to ...
Cached Biology Technology:Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 2Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 3'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny 2'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny 3U.S. Preventive Medicine National Policy Advisor Gov. Tommy Thompson to Propose Prevention is the Solution at UBS Global Health Services Conference 2
(Date:5/18/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, reminds investors and media that  Mr. David Tunnell ... SECURE CONNEXIONS AMERICA 2015, held in Washington DC ... conference is organized into a series of nine session tracks. ... Fraud: Where is the Trust in Cyberspace? and will ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... new study in the July 18 issue of The ... more harmful than their unpigmented relatives. A group of ... have discovered that the molecules that give certain bugs ... cells called neutrophils. , Scientists and clinicians have known ...
... Microbiologists seeking ways to eliminate pollution from waterways with ... in freshwater ponds can generate electricity. They present their ... American Society for Microbiology. , "The bacteria are capable ... used to operate small electronic devices. As long as ...
... of that group of diseases, affects 500 000 people in ... Leishmania infantum, transmitted by sand fly bites. There is no ... if no treatment is given. In the most heavily affected ... acts as parasite reservoir for humans. Development of a vaccine ...
Cached Biology News:Pollution-eating bacteria produce electricity 2Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 2Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 3Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 4
Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
RNA polymerase sigma 70 Immunogen: Recombinant, full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
...
Biology Products: